Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers

Journal of Analytical Toxicology

Volumn 30, Issue 3, 2006, Pages 187-195

  Riedel, Kirsten ^a   Scherer, Gerhard ^a   Engl, Johannes ^a   Hagedorn, Heinz Werner ^a   Tricker, Anthony R ^b  

^a Analytisch Biologisches Forschungslabor GmbH   (Germany)

^b Philip Morris Products SA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLANILINE; 2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; ACID ANHYDRIDE; AROMATIC AMINE; CARBON MONOXIDE; CARCINOGEN; COTININE; NICOTINE; PENTAFLUOROPROPIONIC ANHYDRIDE; TOBACCO SMOKE; UNCLASSIFIED DRUG; 2 TOLUIDINE; 2-TOLUIDINE; 4-BIPHENYLAMINE; AMINOBIPHENYL DERIVATIVE; TOLUIDINE DERIVATIVE;

ANALYTIC METHOD; ARTICLE; BLADDER CANCER; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DERIVATIZATION; EXTRACTION; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; MASS SPECTROMETRY; PASSIVE SMOKING; URINALYSIS; URINARY EXCRETION; URINE LEVEL; ENVIRONMENTAL MONITORING; INDOOR AIR POLLUTION; MASS FRAGMENTOGRAPHY; METHODOLOGY; SMOKING; URINE;

NICOTIANA TABACUM;

2-NAPHTHYLAMINE; AMINOBIPHENYL COMPOUNDS; CARCINOGENS; ENVIRONMENTAL MONITORING; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; SMOKING; TOBACCO SMOKE POLLUTION; TOLUIDINES;

EID: 33747196141     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/30.3.187     Document Type: Article

References (43)

1. G. Talaska. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 21: 29-43 (2003).
2. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. IARC, Lyon, France, 1985.
3. Deutsche Forschungsgemeinschaft. MAK- und BAT-Werte-Liste 1998. Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe. Wiley-VCH, Weinheim, Germany, 1998.
4. Y. Matsuda and D. Hoffmann. Quantitative determination of 1-naphthylamine and 2-naphthylamine in cigarette smoke. Anal. Chem. 41: 650-652 (1969).
5. C. Patrianakos and D. Hoffmann. Chemical studies on tobacco smoke. LXIV. On the analysis of aromatic amines in cigarette smoke. J. Anal. Toxicol. 3: 150-154 (1979).
6. G. Grimmer and D. Schneider. Intercept-reactant method for the determination of aromatic amines in mainstream tobacco smoke. Beiträge zur Tabakforschung Int. 16: 141-156 (1995).
7. C.J. Smith, G.L. Dooly, and S.C. Moldoveanu. New technique using solid-phase extraction for the analysis of aromatic amines in mainstream cigarette smoke. J. Chromatogr. A991: 99-107 (2003).
8. J.B. Forehand, G.L. Dooly, and S.C. Moldoveanu. Analysis of polycyclic aromatic hydrocarbons, phenols and aromatic amines in particulate phase cigarette smoke using simultaneous distillation and extraction as a sole sample clean-up step. J. Chromatogr. A 898: 111-124 (2000).
9. M.F. Borgerding, J.A. Bodnar, and D.E. Wingate. The 1999 Massachusetts Benchmark Study - Final Report. A Research Study Conducted after Consultation with the Massachusetts Department of Public Health. http://www. brownandwilliamson.com/APPS/PDF/Final_Report_1999_Mass_Benchmark_Study.pdf. Accessed 2000.
10. R. Stabbert, K.H. Schafer, C. Biefel, and K. Rustemeier. Analysis of aromatic amines in cigarette smoke. Rapid Commun. Mass Spectrom. 17: 2125-2132 (2003).
11. M.E. Counts, M.J. Morton, S.W. Laffoon, R.H. Cox, and P.J. Lipowicz. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 41: 185-227 (2005).
12. G. Talaska and M. Al Zoughool. Aromatic amines and biomarkers of human exposure. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 21: 133-164 (2003).
13. S.R. Babu, V.M. Lakshmi, G.P. Huang, T.V. Zenser, and B.B. Davis. Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites. pH stability and synthesis by human and dog liver. Biochem. Pharmacol. 51: 1679-1685 (1996).
14. T.V. Zenser, V.M. Lakshmi, and B.B. Davis. N-Glucuronidation of benzidine and its metabolites. Role in bladder cancer. Drug Metab Dispos. 26: 856-859 (1998).
15. G. Talaska, M. Schamer, P. Skipper, S. Tannenbaum, N. Caporaso, L. Unruh, F.F. Kadlubar, H. Bartsch, C. Malaveille, and P. Vineis. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol. Biomarkers Prev. 1: 61-66 (1991).
16. O.S. Son, D.W. Everett, and E.S. Fiala. Metabolism of o-[methyl-14C]toluidine in the F344 rat. Xenobiotica 10: 457-468 (1980).
17. K.L. Cheever, D.E. Richards, and H.B. Plotnick. Metabolism of ortho-, meta-, and para-toluidine in the adult male rat. Toxicol. Appl. Pharmacol. 56: 361-369 (1980).
18. G. Sabbioni and C.R. Jones. Biomonitoring of arylamines and nitroarenes. Biomarkers 7: 347-421 (2002).
19. M.S. Bryant, P.L. Skipper, S.R. Tannenbaum, and M. Maclure. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res. 47: 602-608 (1987).
20. M.S. Bryant, P. Vineis, P.L. Skipper, and S.R. Tannenbaum. Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proceedings of the National Academy of Science United States of America 85: 9788-9791 (1988).
21. M. Riffelmann, G. Muller, W. Schmieding, W. Popp, and K. Norpoth. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int. Arch. Occup. Environ. Health 68: 36-43 (1995).
22. B. Falter, C. Kutzer, and E. Richter. Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Invest. 72: 364-371 (1994).
23. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC Monogr Eval. Carcinog. Risks Hum. 83: 1-1438 (2004).
24. D.H. Phillips. Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23: 1979-2004 (2002).
25. J.A. Williamson, P.H. Lieder, and L. Amegashitsi. Development of a biomonitoring assay for ortho-toluidine or its metabolites in human urine. J. Anal. Toxicol. 19: 256-260 (1995).
26. E.M. Ward, G. Sabbioni, D.G. DeBord, A.W. Teass, K.K. Brown, G.G. Talaska, D.R. Roberts, A.M. Ruder, and R.P. Streicher. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. J. Natl. Cancer Inst. 88: 1046-1052 (1996).
27. A.M. Hansen, O. Omland, O.M. Poulsen, D. Sherson, T. Sigsgaard, J.M. Christensen, and E. Overgaard. Correlation between work process-related exposure to polycyclic aromatic hydrocarbons and urinary levels of alpha-naphthol, beta-naphthylamine and 1-hydroxypyrene in iron foundry workers. Int. Arch. Occup. Environ. Health 65: 385-394 (1994).
28. G. Grimmer, G. Dettbarn, A. Seidel, and J. Jacob. Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci. Total Environ. 247: 81-90 (2000).
29. K. El-Bayoumy, J.M. Donahue, S.S. Hecht, and D. Hoffmann. Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res. 46: 6064-6067 (1986).
30. A.M. Hansen, O.M. Poulsen, and J.M. Christensen. Determination of 2-naphthylamine in urine by a novel reversed-phase high-performance liquid chromatography method. J. Chromatogr. 578: 85-90 (1992).
31. T. Weiss and J. Angerer. Simultaneous determination of various aromatic amines and metabolites of aromatic nitro compounds in urine for low level exposure using gas chromatography-mass spectrometry. J Chromatogr. B 778: 179 (2002).
32. O. Pytela, M. Otyepka, J. Kulhanek, E. Otyepka, and T. Nevecna. Correlation of dissociation constants of 1- and 2,6-substituted anilines in water by methods based on the similarity principle and quantum-chemistry calculations. J. Phys. Chem. A 107: 11489-11496 (2003).
33. T. Hanai, K. Koizumi, and T. Kinoshita. Prediction of retention factors of phenolic and nitrogen-containing compounds in reversed-phase liquid chromatography based on logP and pKa obtained by computational chemical calculations. J. Liq. Chromatogr. Rel. Technol. 23: 363-385 (2000).
34. A.N. Pankratov, I.M. Uchaeva, S. Yu. Doronin, and R.K. Chernova. Correlations between the basicity and proton affinity of substituted anilines. J. Struc. Chem. 42: 739-746 (2001).
35. M. Meger, I. Meger-Kossien, A. Schuler-Metz, D. Janket, and G. Scherer. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography tandem mass spectrometric (LC-MS-MS) detection. J. Chromatogr. B 778: 251-261 (2002).
36. M.C. Bentley, M. Abrar, M. Kelk, M. Cook, J. Cook, and K. Phillips. Validation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. J. Chromatogr. B 723: 185-194 (1999).
37. J.M. Irving, E.C. Clark, I.K. Crombie, and W.C.S. Smith. Evaluation of a portable measure of expired-air carbon monoxide. Preventive Med. 17: 109-115 (1988).
38. M.J. Jarvis, M. Belcher, C. Vesey, and D.C.S. Hutchison. Low cost carbon monoxide monitors in smoking assessment. Thorax 41: 886-887 (1986).
39. K.K. Brown, A.W. Teass, S. Simon, and E.M. Ward. A biological monitoring method for o-toluidine and aniline in urine using high performance liquid chromatography with electrochemical detection. Appl. Occup. Environ. Hyg. 10: 557-565 (1995).
40. Institute of Medicine (IOM). Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. National Academy Press, Washington, D.C., 2001.
41. F. Luceri, G. Pieraccini, G. Moneti, and P. Dolara. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol. Industrial Health 9: 405-413 (1993).
42. G. Scherer and E. Richter. Biomonitoring exposure to environmental tobacco smoke (ETS): a critical reappraisal. Hum. Exp. Toxicol. 16: 449-459 (1997).
43. P.L. Skipper, S.R. Tannenbaum, R.K. Ross, and M.C. Yu. Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 12: 503-507 (2003).